Analyse von Zellfreier Dna in Urin und Anderen Proben
Anmelder: The Chinese University of Hong Kong 🇭🇰
Details
- Veröffentlichungs-Nr.
- EP4752545
- Anmeldetag
- 30. November 2017
- Veröffentlichung
- 3. Juni 2026
- Rechtsraum
- EP
- IPC
- G01N33/493
Abstract
Diseases (e.g., cancer) of a particular organ can be detected by analyzing cell-free DNA. Some embodiments may use an organ-associated sample that is from a particular organ or passes through the particular organ, as may occur, for example, in urine, saliva, blood, and stool samples. In some embodiments, methylation levels of cell-free DNA can be measured in a sample. Tissue-specific methylation patterns can be used to determine fractional contributions from different tissue types. In other embodiments, sizes of organ-associated cell-free DNA can be measured. A statistical measure of the size profile may indicate that cell-free DNA fragments are collectively longer than expected for subjects with healthy tissue compared to non-healthy tissue. In other embodiments, two different samples can be analyzed to determine whether a particular organ has cancer. Cell-free DNA in a blood sample and organ-associated sample can both be analyzed to identify chromosomal regions exhibiting a copy number aberration.
Anmelder
- Firma
- The Chinese University of Hong Kong
- Land
- 🇭🇰 Hongkong
Die Chinese University of Hong Kong ist eine öffentliche Universität in Hongkong mit breiter naturwissenschaftlicher und medizinischer Forschung. Das Patentportfolio konzentriert sich auf Pharma- und Biotechnologie sowie Medizintechnik und Software, ergänzt durch organische Chemie. Anmeldungen reichen von 2000 bis in die Gegenwart.
475 Patente in unserer Datenbank
Fachgebiete
Vertreten von
-
J A Kemp LLP
J A Kemp LLP · London